Health and Healthcare
Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD
The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed bag. Some of the short interest indications doesn’t really look like the short sellers were making the right moves, but time will be the true judge. Here are the key NASDAQ biotech short interest numbers:
Stock (Ticker MAY APRIL CHANGE
Amgen (AMGN) 25.59M 27.99M -8.5%
Gilead (GILD) 12.99M 13.57M -4.2%
Celgene (CELG) 25.9M 24.6M 5%
Genzyme (GENZ) 7.05M 6.75M 4.5%
Medimmune (MEDI) 20.5M 17.2M 18.8%
Biogen-Idec (BIIB) 9.61M 9.09M 5.7%
Amylin Pharma (AMLN) 18.7M 20.0M -6.4%
Imclone (IMCL) 6.26M 7.89M -20.6%
Dendreon (DNDN) 41.6M 33.9M 22.9%
Northfield (NFLD) 6.24M 6.62M -5.7%
Jon C. Ogg
May 25, 2007
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.